Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Sean P. Nolan

CEO at Taysha Gene Therapies, Inc. (TSHA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $840K

Reported trades

Filed Stock Type Shares Price Value Since
Jan 27SEC TSHATaysha Gene Therapies, Inc. Sell 136,7892,949,569 held (−4%) $4.75 $650K -23.8%
Jan 27SEC TSHATaysha Gene Therapies, Inc. Sell 41,3122,908,257 held (−1%) $4.61 $190K -21.5%